Products of other enterprises
Description
Summary of a preparation: Eskolan-sanovel
Structure: Atorvastatin calcium (trigidrat) in the dose equivalent to 10-20-40 mg of an atorvastatin on a tablet.
Pharmacological action: The mechanism of action is connected mainly with violation of synthesis of cholesterol in a liver at a stage of mevalonovy acid owing to selective competitive inhibition of GMG-KOA-reduktazy. Eskolan reduces levels of cholesterol and lipoproteid in plasma due to violation of synthesis of cholesterol in a liver and increases in number and activity of hepatic receptors of LPNP at surfaces of cages that leads to strengthening of capture and a catabolism of LPNP. Increase of the LPVP level and an apolipoprotein is at the same time observed And. The inhibiting effect concerning GMG-KOA reductases approximately on 70 is defined by activity of its circulating metakbolit. Eskolan is quickly soaked up after intake; concentration it in plasma reaches peak during 1-2 h. Extent of absorption raises in proportion to a dose of an atorvastatin.
Indications: Eskolan-Sanovel accept in addition to a diet for decrease in the increased level of the general cholesterol, LNP cholesterol, an apoliprotein In and triglycerides at patients with primary hypercholesterolemia when the diet and other not medicinal methods of treatment do not provide due effect.
Structure: Atorvastatin calcium (trigidrat) in the dose equivalent to 10-20-40 mg of an atorvastatin on a tablet.
Pharmacological action: The mechanism of action is connected mainly with violation of synthesis of cholesterol in a liver at a stage of mevalonovy acid owing to selective competitive inhibition of GMG-KOA-reduktazy. Eskolan reduces levels of cholesterol and lipoproteid in plasma due to violation of synthesis of cholesterol in a liver and increases in number and activity of hepatic receptors of LPNP at surfaces of cages that leads to strengthening of capture and a catabolism of LPNP. Increase of the LPVP level and an apolipoprotein is at the same time observed And. The inhibiting effect concerning GMG-KOA reductases approximately on 70 is defined by activity of its circulating metakbolit. Eskolan is quickly soaked up after intake; concentration it in plasma reaches peak during 1-2 h. Extent of absorption raises in proportion to a dose of an atorvastatin.
Indications: Eskolan-Sanovel accept in addition to a diet for decrease in the increased level of the general cholesterol, LNP cholesterol, an apoliprotein In and triglycerides at patients with primary hypercholesterolemia when the diet and other not medicinal methods of treatment do not provide due effect.
Contact the seller
Eskolan-sanovel
We recommend to see